איקסמפרה 15 מ"ג
País: Israel
Idioma: hebreu
Font: Ministry of Health
Alguns documents d’aquest producte actualment no estan disponibles, podeu enviar una sol·licitud al nostre servei d’atenció al client i us ho notificarem tan bon punt puguem obtenir-los.
Enviar sol.licitud.
Enviar sol.licitud.
ingredients actius:
IXABEPILONE 15 MG
Disponible des:
BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED
Codi ATC:
L01DC04
formulario farmacéutico:
POWDER FOR CONCENTRATE FOR INFUSION
Vía de administración:
I.V
Fabricat per:
CORDEN PHARMA LATINA S.P.A., ITALY
Grupo terapéutico:
IXABEPILONE
indicaciones terapéuticas:
Ixempra is indicated for the treatment of inoperable locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy:In combination with capecitabine in patients failing prior therapy with a taxane and an anthracycline or for whom further anthracycline therapy is not indicated.As monotherapy in patients failing prior therapy with taxanes, capecitabine and anthracyclines or for whom futher anthracycline therapy is not indicated.
Data d'autorització:
2012-01-01
